Indian drugmaker Lupin said on Tuesday it agreed to a $90 million settlement with Japan's Astellas Pharma in a patent dispute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results